Pharmbiopol sp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2016-04-05
Share capital
5,000.00 PLN
Activity description

Pharmbiopol provides contract manufacturing services for dietary supplements, working with production partners. Its services include recipe development, support with registration and documentation, production and packaging, with private-label and white-label options.

Registered address
ul. Ignacego Łukasiewicza 3, 35-604 Rzeszów, Poland
Email
Phone

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 3 of 6 financial statements were filed late (the longest delay 186 days for 2021).

  • 2025not filed
  • 202428/05/2025
  • 202311/09/2024
  • 202230/11/2023
  • 202117/01/2023
  • 202014/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Industry · Wholesale of pharmaceutical goods1,167 / 1,546
Top 75%
Division · Wholesale trade20,984 / 29,082
Top 72%
Voivodeship · Podkarpackie9,635 / 16,391
Top 59%
Country · Poland288,923 / 496,573
Top 58%

Results vs industry

Revenue
This companyUSD 99.21kMedianUSD 1.08mAverageUSD 22.29m
Net profit
This companyUSD -3.19kMedianUSD 38.88kAverageUSD 876.69k
Operating costs
This companyUSD 102.21kMedianUSD 962.19kAverageUSD 20.97m
Assets
This companyUSD 62.99kMedianUSD 609.97kAverageUSD 11.79m

Offer

Websites

The site is available in: Polish and English.

  • pharmbiopol.comProdukcja kontraktowa suplementów diety - Pharmbiopol
    WordPress 3.7ElementorGoogle AnalyticsGoogle Tag ManagerYoast SEOWPMLLiteSpeed

Trademarks

The company holds 2 active trademarks registered with the Polish Patent Office. The first mark was filed in 2025.

MarkNumberClassesStatusProtected until
Famflow Z.5852103, 5Protected May 27, 2035
Baby Bloom Z.5801163, 5Protected Feb 6, 2035
MarkProtected until
Famflow May 27, 2035
Baby Bloom Feb 6, 2035

Authorized Representatives

Krzysztof Chorąży age 53 – President of the Management Board

Manner of representation

In the case of a one-person management board, declarations on behalf of the company are made by the member of the management board. In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
10$135.0610%
90$1,215.5690%

Krzysztof Chorąży and Juliusz Janusz Chorąży hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2016-04-19.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
Symbio-Lab sp. z o.o.
Ossea sp. z o.o.
Pexon Poland sp. z o.o.
Fotam Group sp. z o.o.
Revital Nutrition sp. z o.o.
Nutridea sp. z o.o.
Fuelup Factory sp. z o.o.
BIO Balance Dystrybucja sp. z o.o.
RABO sp. z o.o.
NEST Pharm sp. z o.o.

Change history

DateEvent
2024-10-17Address change
2024-10-04Name change
2024-10-04PKD change
2016-04-05Entered in the register

FAQ

Last updated: 2026-04-17